Education
About Us
Working with TipRanks
Follow Us
Arcadia Biosciences (RKDA)
NASDAQ:RKDA
Earnings Data
Report Date
Aug 13, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.79Last Year’s EPS
0.78Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 08, 2025
|% Change Since: -4.42%
|Next Earnings Date:Aug 13, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted significant growth in Zola's revenue and successful monetization of intellectual property, alongside effective cost management. However, concerns were raised about declining gross margins, a decrease in cash reserves, and uncertainties surrounding the legacy business exit. Despite these challenges, the overall sentiment leans positive due to notable achievements and strategic progress.Company Guidance
During the Arcadia Biosciences, Inc. first-quarter 2025 conference call, the company provided significant guidance on various metrics. Zola, their coconut water brand, saw a 90% year-over-year revenue increase, driven by a 70% rise in new distribution. The sell-through sales grew 76% based on Nielsen data, significantly outpacing the 24% growth in the coconut water category. Operating expenses were reduced by 16% despite incurring nearly half a million dollars in transaction-related fees. Gross margins remained strong, exceeding 30% for the ninth consecutive quarter, although the gross margin rate decreased from 52% in Q1 2024 to 43% in Q1 2025. The company also highlighted the strategic monetization of its intellectual property, resulting in a $750,000 cash gain and a $1,000,000 reduction in liabilities. Additionally, the pending business combination with Roosevelt Resources is progressing, with an anticipated completion around mid-August, and a fixed equity share ratio of 90-10 between Roosevelt partners and Arcadia stockholders was established to provide ownership certainty.Zola Revenue Growth
Zola coconut water revenue grew 90% year-over-year, driven by a 70% increase in new distribution and a 76% increase in scan data sales.
Strong Financial Performance
The company reported a 22% increase in total revenues compared to the same period last year, with Zola being the primary driver.
Cost Management
Operating expenses reduced by 16% year-over-year and gross margins remained strong at 43%.
Monetization of Intellectual Property
The company received $750,000 in cash from a transaction involving its soy patents, eliminating a $1,000,000 contingent liability.
Pending Combination with Roosevelt Resources
The business combination with Roosevelt Resources is progressing and is on track to be completed around August 15.
RKDA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
RKDA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 08, 2025 | $4.30 | $4.29 | -0.23% |
Mar 20, 2025 | $3.30 | $3.15 | -4.55% |
Nov 12, 2024 | $4.24 | $4.19 | -1.18% |
Aug 13, 2024 | $2.99 | $2.66 | -11.04% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Arcadia Biosciences (RKDA) report earnings?
Arcadia Biosciences (RKDA) is schdueled to report earning on Aug 13, 2025, TBA Not Confirmed.
What is Arcadia Biosciences (RKDA) earnings time?
Arcadia Biosciences (RKDA) earnings time is at Aug 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is RKDA EPS forecast?
RKDA EPS forecast for the fiscal quarter 2025 (Q2) is -0.79.